BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:56 AM | Browse: 122 | Download: 342
 |
Received |
|
2025-08-11 01:23 |
|
Peer-Review Started |
|
2025-08-11 01:23 |
|
First Decision by Editorial Office Director |
|
2025-09-03 10:07 |
|
Return for Revision |
|
2025-09-03 22:09 |
|
Revised |
|
2025-09-14 13:23 |
|
Publication Fee Transferred |
|
2025-09-18 21:53 |
|
Second Decision by Editor |
|
2025-10-31 02:34 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-31 08:43 |
|
Articles in Press |
|
2025-10-31 08:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-01 11:15 |
|
Publish the Manuscript Online |
|
2025-12-11 08:20 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Geriatrics & Gerontology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Tumor-resident microorganisms as clinical biomarkers in primary liver cancer: A systematic review of current evidence
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shuai Song, Li-Shan Xu, Lin-Qing Wang, Xiu Zhou, Xin Jiang and Chang-Ping Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xin Jiang, Department of Gastroenterology, The First Affiliated Hospital of Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou 310000, Zhejiang Province, China. jx10818030@zju.edu.cn |
| Key Words |
Intratumoral microbiota; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Diagnosis; Prognosis; Therapeutic response; Gut-liver axis; 16S rRNA sequencing; Biomarkers; Systematic review |
| Core Tip |
Once considered sterile environments, hepatic malignancies are now recognized to harbor distinct microbial communities with significant clinical implications. This systematic review of 20 high-quality studies demonstrates that intratumoral microbes represent promising biomarkers across multiple applications in liver cancer. Specific bacterial taxa achieved exceptional diagnostic accuracy (area under the curve > 0.9), while microbial diversity patterns showed consistent prognostic associations with patient survival outcomes. Mechanistic investigations revealed microbe-mediated oncogenic pathway activation, immune modulation, and drug resistance mechanisms. These findings position tumor-resident microorganisms at the threshold of clinical translation, offering novel opportunities for precision diagnosis, prognostic stratification, and personalized treatment strategies in hepatic malignancy management. |
| Publish Date |
2025-12-11 08:20 |
| Citation |
Song S, Xu LS, Wang LQ, Zhou X, Jiang X, Li CP. Tumor-resident microorganisms as clinical biomarkers in primary liver cancer: A systematic review of current evidence. World J Gastrointest Oncol 2025; 17(12): 112936 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i12/112936.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i12.112936 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
